Pfizer ends commercialization of Beqvez hemophilia B gene therapy. CEO Kim Phelan of Coalition for Hemophilia B expresses ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
We recently compiled a list of the 10 Best Non-Tech Stocks to Buy Now for Long Term. In this article, we are going to take a ...
Pfizer said on Thursday it will stop global development and commercialization of its hemophilia gene therapy, Beqvez, citing ...
There are plenty of great investment alternatives in the healthcare sector. You won't need a boatload of money to get started, either. Here are two no-brainer healthcare stocks to buy with $500 right ...
New Delhi: Pfizer Ltd on Friday said its board has approved signing a marketing and supply agreement with Mylan ...
Pfizer has announced that it has entered into a marketing and supply agreement with Mylan Pharmaceuticals for the marketing and sale of two of its brands, Ativan and Pacitane.
Mylan, which has an established presence in the central nervous system therapy segment, is expected to leverage its network ...
Additional data from CheckMate 274 showed that adjuvant nivolumab benefits patients with muscle-invasive bladder cancer with ...
Greek-American Pfizer CEO Dr Albert Bourla faced an unwelcoming reception at the White House during an event celebrating ...
The CEO of Pfizer received loud boos when he was introduced by Donald Trump at a Black History Month event at the White House ...
Refugees tend to work hard, are loyal to their employers and often are more willing to relocate than other hires because they ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results